Grant Round 18 is OPEN!
Could your team use non-dilutive funding to develop a life sciences innovation into commercialization? Then you're at the right place because Virginia Catalyst is now accepting Letters of Intent for Grant Round 18!
We encourage those of you with innovative ideas in life sciences to reach out to colleagues and other professionals to create a high-performing team - because we know that world class research, entrepreneurial management and capital can achieve great things together. Now is the time to get your team together and submit an LOI by March 14th
We encourage those of you with innovative ideas in life sciences to reach out to colleagues and other professionals to create a high-performing team - because we know that world class research, entrepreneurial management and capital can achieve great things together. Now is the time to get your team together and submit an LOI by March 14th
Round 18 Timeline
November 12, 2024 – Now accepting Letters of Intent (LOI) for Grant Round 18
March 14, 2025 5:00 PM Eastern Deadline to submit LOI for consideration in Grant Round 18
Invitation to submit a full application will be sent to Applicant Teams whose LOI meets funding criteria
April 30, 2025 5:00 PM Eastern Deadline to submit full application for Grant Round 18
May 31, 2025 Invitation to present proposal in person to our Project Management and Oversight Panel (PMOP) will be sent to the top 8 applicant teams as determined by scoring and ranking of applications
June 10, 2025 Proposal Presentations
June 17, 2025 Virginia Board of Directors final funding decision for Grant Round 18
June 2025 Grant Round 18 Awardees announced
March 14, 2025 5:00 PM Eastern Deadline to submit LOI for consideration in Grant Round 18
Invitation to submit a full application will be sent to Applicant Teams whose LOI meets funding criteria
April 30, 2025 5:00 PM Eastern Deadline to submit full application for Grant Round 18
May 31, 2025 Invitation to present proposal in person to our Project Management and Oversight Panel (PMOP) will be sent to the top 8 applicant teams as determined by scoring and ranking of applications
June 10, 2025 Proposal Presentations
June 17, 2025 Virginia Board of Directors final funding decision for Grant Round 18
June 2025 Grant Round 18 Awardees announced
Our Strategic Initiatives - Actions and Results for Virginia
At the Virginia Catalyst we specialize in developing and leading strategic initiatives in areas were Virginia can be a national and global leader. We support these initiatives with grant funding for collaborative projects, investments creating research tools, and infrastructure that provide our research universities, healthcare systems and companies a competitive advantage over other regions in the country.
|
Our goal is to have the Commonwealth of Virginia be the very best in the nation at translational medicine and commercialization. We will achieve this by teaming up the biosciences industry with our world-class academic researchers and focusing efforts on solving large unmet medical needs. – Michael Grisham, CEO |
Bringing Virginia Results!
Our competitive grant funding rounds brought Virginia a 28-to-1 return on investment and added over 400 jobs!
|
Grant Funding Program
Continuing powerful impact through our Grant Funding Program
Funding through our Grant Funding Program is designed to facilitate the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy. Virginia Catalyst awards these funds to help accelerate translational research and the commercialization of Virginia’s innovations. The awards, which range from $200,000 to $800,000, help fund collaborative efforts between industry and Virginia research universities.
Continuing powerful impact through our Grant Funding Program
Funding through our Grant Funding Program is designed to facilitate the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy. Virginia Catalyst awards these funds to help accelerate translational research and the commercialization of Virginia’s innovations. The awards, which range from $200,000 to $800,000, help fund collaborative efforts between industry and Virginia research universities.
Thank you to the Sponsors of the Catalyst Life Sciences Conference
October 6-7, 2022!
Gold Sponsors
|
|
|
Champions of Life Sciences Sponsors
|
|
Special Webinar - How to Score High and Get Funding
Previously the Virginia Catalyst and Virginia Bio co-hosted a special webinar that featured a panel of experts sharing what it takes to score highly and get funding.
Panel members:
Mike Grisham, President and CEO, Virginia Catalyst, Founder and CEO, GPB Scientific, Inc.
Mickey Kim, former Senior Vice President, Research and Commercialization, Inova Translational Medicine Institute
James Powers, Chairman and CEO, HemoShear Theapeutics, LLC
Thomas D. Roberts III, General Partner, Harbert Growth Partners, Harbert Management Corporation
Read the full press release here
Download the presentation slides
Panel members:
Mike Grisham, President and CEO, Virginia Catalyst, Founder and CEO, GPB Scientific, Inc.
Mickey Kim, former Senior Vice President, Research and Commercialization, Inova Translational Medicine Institute
James Powers, Chairman and CEO, HemoShear Theapeutics, LLC
Thomas D. Roberts III, General Partner, Harbert Growth Partners, Harbert Management Corporation
Read the full press release here
Download the presentation slides
|
|
About the Virginia Catalyst
We are a not-for-profit 501(c)(3) corporation created by the Virginia General Assembly and funded by the Commonwealth’s General Fund and seven Virginia public research universities: Eastern Virginia Medical School, George Mason University, Old Dominion University, University of Virginia, Virginia Commonwealth University, and Virginia Tech.
Our Mission
Our mission is to advance economic development by creating competitive critical mass for Virginia life sciences through collaborations with our research universities and industry, to attract research and commercialization capital to Virginia and to catalyze the commercialization of Virginia’s innovations that meet large, unmet medical needs, improve human health and to create many more high-paying life science jobs in Virginia.
